Literature DB >> 7531682

Risk factors related to liver metastasis in colorectal carcinoma: a multivariate analysis of clinicopathologic and immunohistochemical variables.

E Nagai1, T Yao, M Sakamoto, K Akazawa, T Utsunomiya, M Tsuneyoshi.   

Abstract

Specimens from 48 consecutive patients undergoing surgery for colorectal carcinoma and having synchronous or metachronous liver metastases (Group 1) and those from 52 consecutive patients who had no evidence of hepatic metastases within at least 5 year after colorectal resection (Group 2) were selected and compared using a multiple logistic regression analysis. A multivariate analysis using a stepwise logistic regression revealed six independent risk factors significantly related to hepatic metastases. In addition, the following logistic regression model was obtained from this analysis. P = exp a/(1 + exp a): a = 3.524(SM-V) + 2.731(Ex-V) + 2.718(E/M) + 2.562(Lo) + 1.858(p53) + 1.941(HIR) - 4.397, where P is the probability of hepatic metastasis given six independent risk factors (E/M, Ex/M ratio; Lo, location; HIR, host inflammatory cell reaction). When the estimated probability "P" in the above logistic regression model is more than 0.55 after an examination of surgical specimens, we must consider adjuvant chemotherapy and closely monitor the patient to ensure early detection of hepatic metastases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7531682      PMCID: PMC5919398          DOI: 10.1111/j.1349-7006.1994.tb02941.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  29 in total

Review 1.  The clinical significance of vascular invasion in colorectal cancer.

Authors:  B Minsky; C Mies
Journal:  Dis Colon Rectum       Date:  1989-09       Impact factor: 4.585

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Estimating odds ratios with categorically scaled covariates in multiple logistic regression analysis.

Authors:  S Lemeshow; D W Hosmer
Journal:  Am J Epidemiol       Date:  1984-02       Impact factor: 4.897

4.  Resection and embolization in the management of secondary hepatic tumors.

Authors:  L H Blumgart; D J Allison
Journal:  World J Surg       Date:  1982-01       Impact factor: 3.352

5.  Influence of tumour site on presentation, management and subsequent outcome in large bowel cancer.

Authors:  M C Aldridge; R K Phillips; R Hittinger; J S Fry; L P Fielding
Journal:  Br J Surg       Date:  1986-08       Impact factor: 6.939

6.  Resection of hepatic metastases from colorectal cancer.

Authors:  M A Adson; J A van Heerden; M H Adson; J S Wagner; D M Ilstrup
Journal:  Arch Surg       Date:  1984-06

7.  Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis.

Authors:  A Yamaguchi; Y Kurosaka; S Fushida; M Kanno; Y Yonemura; K Miwa; I Miyazaki
Journal:  Cancer       Date:  1992-12-15       Impact factor: 6.860

8.  Morbidity and survival of liver resection for colorectal adenocarcinoma.

Authors:  N Petrelli; B Gupta; M Piedmonte; L Herrera
Journal:  Dis Colon Rectum       Date:  1991-10       Impact factor: 4.585

9.  Major hepatic resection for neoplasia: personal experience in 108 patients.

Authors:  J G Fortner; D K Kim; B J Maclean; M K Barrett; S Iwatsuki; A D Turnbull; W S Howland; E J Beattie
Journal:  Ann Surg       Date:  1978-09       Impact factor: 12.969

10.  The clinical significance of invasion of veins by rectal cancer.

Authors:  I C Talbot; S Ritchie; M H Leighton; A O Hughes; H J Bussey; B C Morson
Journal:  Br J Surg       Date:  1980-06       Impact factor: 6.939

View more
  1 in total

1.  Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer: a novel approach from immune/inflammatory aspect.

Authors:  S Takeha; Y Fujiyama; T Bamba; T Sorsa; H Nagura; H Ohtani
Journal:  Jpn J Cancer Res       Date:  1997-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.